The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.
about
Scavenger Receptors: Emerging Roles in Cancer Biology and ImmunologyCD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma.Tumor-associated macrophages promote Ezrin phosphorylation-mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulationHigh-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancerCCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma modelA Potential Inhibitory Profile of Liver CD68+ Cells during HCV Infection as Observed by an Increased CD80 and PD-L1 but Not CD86 Expression.Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro.Increased CD86 but Not CD80 and PD-L1 Expression on Liver CD68+ Cells during Chronic HBV Infection.Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosisTumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinomaCD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient PrognosisA high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients.Clinical significance of macrophage heterogeneity in human malignant tumors.Cellular prognostic markers in hepatocellular carcinoma.Role of tumor-associated macrophages in human malignancies: friend or foe?Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value.CD68/macrosialin: not just a histochemical marker.Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma.OPN sesame.Characterization of the Immune Microenvironment in Hepatocellular Carcinoma (HCC).The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with hepatocellular carcinoma: A meta-analysisThe clue of a possible etiology about spontaneous regression of hepatocellular carcinoma: a perspective on pathology.Signal Transducer and Activator of Transcription 3 for the Differentiation of Hepatocellular Carcinoma from Cirrhosis.Differential effects of endurance training and weight loss on plasma adiponectin multimers and adipose tissue macrophages in younger, moderately overweight men.[Tumor-associated macrophages: Function and differentiation].Prognostic significance of CD68, CD163 and Folate receptor-β positive macrophages in hepatocellular carcinoma.Drug response prediction model using a hierarchical structural component modeling method
P2860
Q26799114-2CBDB333-E1DB-4B80-8D70-D31C086C23A0Q33657026-23000D0E-1148-491A-BFC7-667BC2E93EA2Q33709659-E8DFE362-A35E-4DCF-9774-BF147B9680FCQ35010242-74D4BD75-2AAE-4EC8-99E7-9953DC0EB053Q35067403-C49E8F69-9B58-488C-8EF5-E6416D8889CFQ35985861-72D217C5-056A-4CC7-B1D1-17098214D620Q36027111-F3B2FE53-52D2-4659-8BF2-6A05F53B6571Q36062362-76E676D0-8638-4C47-B64D-474F91826356Q36145296-C5500777-9E6D-43E3-9001-8E32E44FE22AQ36190325-AF696E56-17C4-48F5-AA01-C2255A5C7D03Q36466730-4764149E-3F61-48AC-8BE7-B03A6B5C11A5Q36743574-1527DFC5-BF6C-471E-9627-F587698F3801Q37612098-2E679A95-3A6E-45C2-AA70-19C720DA68B1Q38156195-7C437D6F-9816-4E2C-837F-4EB7C7CFC4D8Q38515812-E862EB10-BB3D-402B-B692-4B0A26DC28E9Q38904869-34D9F1BA-9FC1-4EF3-968B-5A1E1A33A5F7Q40143234-99D868C2-3B8A-4A6D-B719-9E45C59DAD4DQ40442574-06C4F3ED-2EFB-4231-9793-099DA563B89BQ41139490-E719B698-02D5-40FE-9FD0-84519D6F9D90Q41350943-1768407F-FF7A-4710-AF94-3C7EB9AF32E7Q41934377-B4D3EC59-71DA-420A-844D-BF683E923DEAQ42291176-73FC12C5-5727-496E-BC18-73812412E99FQ43151924-7ACDCDAD-B989-4F18-A038-970E23397222Q47153625-D0B8AD36-68D1-435D-A653-D1AD3F5B05C0Q47224030-BFB5BD41-BB0B-4E54-8C3B-801109402196Q48579607-99440838-AF09-4C61-8927-3AF59382CA7AQ54997186-43CB38DA-0479-4188-A782-62078A7F13D1Q58785493-D709DACE-CC2E-408C-B271-BF357BE89891
P2860
The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The clinical significance of t ...... with hepatocellular carcinoma.
@ast
The clinical significance of t ...... with hepatocellular carcinoma.
@en
The clinical significance of t ...... with hepatocellular carcinoma.
@nl
type
label
The clinical significance of t ...... with hepatocellular carcinoma.
@ast
The clinical significance of t ...... with hepatocellular carcinoma.
@en
The clinical significance of t ...... with hepatocellular carcinoma.
@nl
prefLabel
The clinical significance of t ...... with hepatocellular carcinoma.
@ast
The clinical significance of t ...... with hepatocellular carcinoma.
@en
The clinical significance of t ...... with hepatocellular carcinoma.
@nl
P2093
P2860
P1433
P1476
The clinical significance of t ...... with hepatocellular carcinoma
@en
P2093
Hua-Xiang Xu
Hui-Chuan Sun
Ju-Bo Zhang
Ling-Qun Kong
Qiang-Bo Zhang
Wei-Zhong Wu
Wen-Quan Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0059771
P407
P577
2013-03-29T00:00:00Z